Nalaganje...
A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial
STUDY OBJECTIVE: A safe alternative to erythropoiesis‐stimulating agents to treat anemia is warranted in patients with cancer and anemia; thus the objective of this trial was to compare the efficacy and safety of intravenous (IV) iron isomaltoside with oral iron in patients with cancer and anemia by...
Shranjeno v:
izdano v: | Pharmacotherapy |
---|---|
Main Authors: | , , , , , |
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
John Wiley and Sons Inc.
2016
|
Teme: | |
Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5071650/ https://ncbi.nlm.nih.gov/pubmed/26927900 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1729 |
Oznake: |
Označite
Brez oznak, prvi označite!
|